Amgen shares fall after MariTide fails to become top weight-loss company News ad
Amgen today $272.58 -1.75 (-0.64%) (As of 12/6/2024 8:53 PM ET) 52 week range $257.80 ▼ $346.85 Dividend yield 3.30% P/E ratio 34.90 Target price $323.05 Amgen NASDAQ:AMGN recently published clinical results from the development of the weight loss drug MariTide. The next day, shares fell as much as 12%. However, they recovered, leaving the … Read more
